|
IQVIA™ Real-World Insights Bibliography
| Use of maximum medical therapy in primary open-angle glaucoma: a retrospective, electronic medical records-based study from the UK |
| Author(s): Costa VP1, Durus A2, Gondos A3, Bezlyak V2, Wintermantel T3, Sagkriotis A2, Hubatsch D4, Kim YS2 |
| Affiliations(s): 1: Department of Ophthalmology, University of Campinas, Sao Paulo, Brazil; 2: Novartis Pharma AG, Basel, Switzerland; 3: Real World Insights, IQVIA, Basel, Switzerland; 4: Novartis Pharmaceutical Corporation Inc, Fort Worth, TX, USA |
Publication(s): Wolrd Glaucoma Congress, Melbourne, Australia, 27-30 March 2019
|
| Document Type(s): Poster, |
| Countries: UK, |
C:
Y: |
Ophthalmology,
2019 |
|
L:
A: |
English
clinical setting: Secondary care, Epidemiological study, Retrospective database analysis, |
|
 |
| |
| |
| Association between changes in anatomical and functional outcomes and physicians? decisions to treat patients with licensed anti-VEGFs for neovascular age-related macular degeneration in the UK |
| Author(s): Chakravarthy U1, Kap E2, Pillai N2, Syntosi A3, Sagkriotis A3 |
| Affiliations(s): 1. Centre for Experimental Medicine, Institute of Clinical Science, Queen's University Belfast, Belfast, UK; 2. IQVIA, Switzerland, Germany; 3. Novartis Pharma AG, Basel, Switzerland |
Publication(s): 19th EURETINA Congress, Paris, France, 5-8 September 2019
|
| Document Type(s): Oral presentation, |
| Countries: UK, |
C:
Y: |
Ophthalmology,
2019 |
|
L:
A: |
English
clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective database analysis, |
|
|
| |
| |
| Drug utilization and associated visual acuity in patients treated with anti-VEGFs for neovascular age-related macular degeneration (nAMD) in the UK |
| Author(s): Sagkriotis A1, Bennett N2, Skelly A1, Venkatesan S3, Oyetunde S2 |
| Affiliations(s): 1. Novartis Pharma AG, Basel, Switzerland; 2. Novartis Pharmaceuticals UK Limited, Surrey, United Kingdom; 3. IQVIA Real World Insights, UK |
Publication(s): 19th EURETINA Congress, Paris, France, 5-8 September 2019
|
| Document Type(s): Poster, |
| Countries: UK, |
C:
Y: |
Ophthalmology,
2019 |
|
L:
A: |
English
clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective database analysis, |
|
|
| |
| |
| Long term treatment patterns and visual outcomes of anti-vascular endothelial growth factor agents among people with neovascular age-related macular degeneration in the US |
| Author(s): Skelly A1, Khanani AM2, Griner R3, Bezlyak V1, Clark J4, Sagkriotis A1 |
| Affiliations(s): 1. Novartis Pharma AG, Basel, Switzerland; 2. Sierra Eye Associates, Reno, Nevada, USA; 3. IQVIA, Cambridge, MA, US; 4. Novartis Pharmaceuticals, East Hanover, NJ, US |
Publication(s): ARVO, Vancouver, Canada, April 28 - May 2 2019
|
| Document Type(s): Poster, |
| Countries: USA, |
C:
Y: |
Ophthalmology,
2019 |
|
L:
A: |
English
clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective database analysis, |
|
|
| |
| |
| Clinical effectiveness of switching between ranibizumab and aflibercept in treatment of neovascular AMD: US real-world outcomes |
| Author(s): Dugel PU1, Griner R2, Ferreira A3, Milnes F3, Lotery AJ4 |
| Affiliations(s): 1. Retinal Consultants of Arizona LTD, Retinal Research Institute LLC, Phoenix, AZ, USA; 2. IQVIA Real World Solutions, USA; 3. Novartis Pharma AG, Basel, Switzerland; 4. Eye Unit, University Hospital Southampton NHS Foundation Trust, Southampton, UK |
Publication(s): J Vitreoretin Dis. 2019 3(3):127-134
|
| Document Type(s): Article, |
| Countries: USA, |
| Click here for the abstract |
C:
Y: |
Ophthalmology,
2019 |
|
L:
A: |
English
clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective database analysis, |
|
|
| |
| |
| Treat and extend treatment interval patterns with anti-VEGF therapy in nAMD patients |
| Author(s): Skelly A1, Bezlyak V1, Liew G2, Kap E3, Sagkriotis A1 |
| Affiliations(s): 1. Novartis Pharma AG, 4002 Basel, Switzerland; 2. Westmead Institute for Medical Research, University of Sydney, Westmead NSW 2145, Australia; 3. IQVIA Commercial GmbH & Co. OHG, 60549 Frankfurt, Germany |
| Publication(s): |
| Document Type(s): Article, |
| Countries: Australia, |
| Click here for the abstract |
C:
Y: |
Ophthalmology,
2019 |
|
L:
A: |
English
clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective database analysis, |
|
|
| |
| |
| Anti-VEGF persistence and switching in nAMD: real world analysis from a Canadian claims database |
| Author(s): Tina Maio-Twofoot 1, Alexandros Sagkriotis 2, Atif Kukaswadia 3, Fran?ois Lebeau 1, Valerie Gregory 1 |
| Affiliations(s): 1 Novartis Pharmaceuticals Canada Inc., 2 Novartis Pharma AG; 3 IQVIA |
| Publication(s): |
| Document Type(s): Poster, |
| Countries: Canada, |
C:
Y: |
Ophthalmology,
2019 |
|
L:
A: |
English
Longitudinal study, Observational study, Retrospective database analysis, |
|
|
| |
| |
| US Multicenter Study of Time, Operational and Economic Efficiences Associated with Using a New Preloaded IOL Delivery System |
| Author(s): Damien Goldberg, Katharine Coyle, Michael Jones, Stephen Lane, Terry Kim. Michael Keith |
| Affiliations(s): Damien Goldberg, Wolstan and Goldberg Eye Associates, Katharine Coyle, IQVIA |
Publication(s): Conference
|
| Document Type(s): Abstract, |
| Countries: USA, |
| Click here for the abstract |
C:
Y: |
Ophthalmology,
2018 |
|
L:
A: |
English
Observational study, |
|
|
| |
| |
| Real World Prescription Patterns of Beta-Blocker-Free Combination Treatment in the UK |
| Author(s): Yongsoo Kim, Judit Banhazi, Alexandra Durus, Laura Rodriguez Torres, Adam Gondos, Daniel Viriato, Vladimir Bezlyak, Naomi Boxall, Tim Wintermantel, Alexandros Sagkriotis & Douglas A Hubatsch |
| Affiliations(s): |
Publication(s): 13th EGS Congress, Florence, Italy - P4.034
|
| Document Type(s): Abstract, Poster, |
| Countries: UK, |
| Click here for the abstract |
C:
Y: |
Ophthalmology,
2018 |
|
L:
A: |
English
Retrospective database analysis, |
|
|
| |
| |
| Treatment Pathways of Primary Open Angle Glaucoma Prior to Laser Surgery: Real World Evidence from UK Ophthalmology Clinics |
| Author(s): Yongsoo Kim, Judit Banhazi, Alexandra Durus, Laura Rodriguez Torres, Adam Gondos, Daniel Viriato, Vladimir Bezlyak, Naomi Boxall, Tim Wintermantel, Alexandros Sagkriotis & Douglas A Hubatsch |
| Affiliations(s): |
Publication(s): Investigative Ophthalmology & Visual Science July 2018, Vol.59, 6109
|
| Document Type(s): Abstract, |
| Countries: UK, |
| Click here for the abstract |
C:
Y: |
Ophthalmology,
2018 |
|
L:
A: |
English
|
|
|
| |
| |
 1 of 11 
|
|
